| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 06/28/2007 | WO2007072965A1 Angiogenesis inhibitor and utilization of the same |
| 06/28/2007 | WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv) |
| 06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | WO2007042040A3 TREATMENT OF RETINOPATHIES USING GFRα3 AGONISTS |
| 06/28/2007 | WO2007025275A3 Control of induced elevated intraocular pressure |
| 06/28/2007 | WO2007002781A3 Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells |
| 06/28/2007 | US20070149587 Valsartan Salts |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070148734 Hyaluronic acid mediated adenoviral transduction |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148158 Rationally designed heparinases derived from heparinase II |
| 06/28/2007 | CA2634056A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/27/2007 | EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 06/27/2007 | EP1801108A1 Morpholine compound |
| 06/27/2007 | EP1799204A1 Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 06/27/2007 | EP1799200A1 Polyamine analogs as therapeutic agents for ocular diseases |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1343779B1 Novel compounds |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1061913B1 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy |
| 06/27/2007 | CN1989439A Methods and compositions for the treatment of uveitis |
| 06/27/2007 | CN1985815A Local medicine preparation containing antiinfective medicine composition and its preparing method |
| 06/27/2007 | CN1985801A Benzydalysine eye drop and its preparing method |
| 06/27/2007 | CN1985664A Double egg white food for teenage and its making process |
| 06/27/2007 | CN1323079C Renin inhibitors |
| 06/27/2007 | CN1322859C Utilization of a highly fluorinated oligomeric alkan in ophthalmology |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235586 prostaglandin derivatives such as (Z)-7-((1R,2S,3R)-2-Butylcarbamoyloxymethyl-3-hydroxy-5-oxo-cyclopentyl)-hept-5-enoic acid methyl ester, administering to mammals for treatment of ocular hypertension; hypotensive agents |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235556 triazolo[1,5,b]pyridazine and imidazo[1,2,b]pyridazine derivatives, especially for treating symptoms of dry eye associated with refractive surgery. |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235535 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 06/26/2007 | US7235247 Aqueous solution; efficient penetration |
| 06/26/2007 | CA2379605C Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/21/2007 | WO2007070866A2 Control of intraocular pressure using alk5 modulation agents |
| 06/21/2007 | WO2007070413A1 Treatment of corneal ulcers with topical gatifloxacin |
| 06/21/2007 | WO2007069712A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | WO2007069669A1 Pharmaceutical composition for enhancing adiponectin production |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069621A1 Novel composition and method for production thereof |
| 06/21/2007 | WO2007069378A1 Drug package |
| 06/21/2007 | WO2007068171A1 CRYSTALLINE FORM I OF 3,4',5-TRIHYDROXY-STIBENE-3-β-D-GLUCOSIDE |
| 06/21/2007 | WO2007011880A3 Enhanced ocular neuroprotection/neurostimulation |
| 06/21/2007 | WO2006127592A8 Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070142718 Noninvasive measurement of chemical substances |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 06/21/2007 | US20070142449 Angiogenesis inhibitors |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070141029 Methods of gene therapy for treating disorders of the ear by adminstering a vector encoding an antonal-associated factor |
| 06/21/2007 | US20070140984 Functional powdery product |
| 06/21/2007 | CA2633374A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | CA2629432A1 Control of intraocular pressure using alk5 modulation agents |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798226A1 Triazole derivative |
| 06/20/2007 | EP1797894A2 Vaccine composition |
| 06/20/2007 | EP1797888A1 Ophthalmic composition containing xanthan gum and amino acid |
| 06/20/2007 | EP1797082A1 Carbostyril compound |
| 06/20/2007 | EP1796675A2 Compositions and methods for treating ophthalmic diseases |
| 06/20/2007 | EP1796657A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/20/2007 | EP1796628A1 New viscoelastic composition, methods of use and packaging device with anti-oxidant |
| 06/20/2007 | EP1796624A2 Use of a viscoelastic composition for treating increased intraocular pressure |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1981886A Nasal delivery devices |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1321691C Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |
| 06/20/2007 | CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 06/20/2007 | CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232881 Peptide containing Ser-Ser-Ser-Arg |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 06/19/2007 | US7232568 Compositions and methods for treating hyperimmune response in the eye |
| 06/14/2007 | WO2007067981A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/14/2007 | WO2007067807A1 Tetracyclines for treating ocular diseases and disorders |
| 06/14/2007 | WO2007066928A1 Use of the extract of caesalpinia sappan l. and compounds therefrom |
| 06/14/2007 | WO2007066678A1 Therapeutic agent for corneal/conjuctival disease |
| 06/14/2007 | WO2007065450A1 Means for preventing and treating conjunctivitis of different ethiology (variants) and a method for the use thereof |
| 06/14/2007 | WO2006104897A3 Cytoskeletal active compounds, composition and use |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135412 Compounds for the treatment of ocular dryness caused by photorefractive surgery |
| 06/14/2007 | US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 06/14/2007 | US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | DE102006051512A1 Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin Pharmaceutical compositions medication with cyclosporine |
| 06/14/2007 | CA2632568A1 Tetracyclines for treating ocular diseases and disorders |